TrialMedical oncology (Northwood, London, England)2014

High-dose idarubicin plus busulfan as conditioning regimen to autologous stem cell transplantation: promising post-remission therapy for acute myeloid leukemia in first complete remission?

Ming Hong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.